Kyprolis 30mg (Carfilzomib Vials) 30mgx15ml

Kyprolis 30mg (Carfilzomib) is a prescription medication used in cancer treatment. It comes in vial form for injection, with each vial containing 30mg per 15ml. Store between 2-8°C to maintain potency. Always follow healthcare provider instructions for use.

Strength

30mgx15ml

Pack Size

Storage

2-8°

Manufacturer / TM Owner

Amgen

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Kyprolis 30mg is used to treat multiple myeloma, a type of blood cancer. It works by slowing or stopping the growth of cancer cells. Patients often receive this medication as part of a combination therapy. It is prescribed when other treatments have not been effective.

Side Effects

Kyprolis 30mg may help reduce cancer symptoms and slow disease progression. Some patients experience fatigue, nausea, or changes in blood cell counts during treatment. Regular monitoring by a healthcare provider is recommended to track progress and manage any side effects.

Precautions & Warnings

Store Kyprolis 30mg vials refrigerated between 2-8°C and protect from light. Do not freeze or shake the vials. Always check the expiration date before use. Dispose of unused medication properly according to local regulations. Keep out of reach of children.

Avoid Interactions

Kyprolis may interact with other medications, including blood pressure drugs and certain antibiotics. Avoid grapefruit products as they may affect how the medication works. Inform your healthcare provider about all medications and supplements you are taking. Some interactions may require dose adjustments.

References

Frequently Asked Questions

Kyprolis 30mg is used to treat multiple myeloma, a type of blood cancer, when other treatments have not been effective.

Kyprolis 30mg is given as an injection by a healthcare professional, typically in a clinical setting.

Common side effects may include fatigue, nausea, or changes in blood cell counts. Discuss any concerns with your healthcare provider.

No, Kyprolis 30mg must be stored refrigerated between 2-8°C to maintain its effectiveness.

Yes, Kyprolis 30mg is a prescription medication and should only be used under medical supervision.

Published by GNH India Pharmaceuticals Limited

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.